Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;136(5):1047-1058.
doi: 10.1097/AOG.0000000000004096.

Primary Dysmenorrhea: Diagnosis and Therapy

Affiliations
Review

Primary Dysmenorrhea: Diagnosis and Therapy

Elizabeth Ferries-Rowe et al. Obstet Gynecol. 2020 Nov.

Abstract

Primary dysmenorrhea is defined as pain during the menstrual cycle in the absence of an identifiable cause. It is one of the most common causes of pelvic pain in women. Dysmenorrhea can negatively affect a woman's quality of life and interfere with daily activities. The pathophysiology of primary dysmenorrhea is likely a result of the cyclooxygenase pathway producing increased prostanoids, particularly prostaglandins (PGs). The increased PGs cause uterine contractions that restrict blood flow and lead to the production of anaerobic metabolites that stimulate pain receptors. Women with a history typical for primary dysmenorrhea can initiate empiric treatment without additional testing. Shared decision making is key to effective management of dysmenorrhea to maximize patient compliance and satisfaction. After a discussion of their risks and benefits, extremely effective empiric therapies are nonsteroidal antiinflammatory drugs and contraceptive hormonal therapy. Other treatments for primary dysmenorrhea can be employed solely or in combination with other modalities, but the literature supporting their use is not as convincing. The physician should initiate an evaluation for secondary dysmenorrhea if the patient does not report improved symptomatology after being compliant with their medical regimen.

PubMed Disclaimer

Comment in

  • Primary Dysmenorrhea: Diagnosis and Therapy.
    Tu F, Hellman K. Tu F, et al. Obstet Gynecol. 2021 Apr 1;137(4):752. doi: 10.1097/AOG.0000000000004341. Obstet Gynecol. 2021. PMID: 33759824 Free PMC article. No abstract available.
  • In Reply.
    Ferries-Rowe E. Ferries-Rowe E. Obstet Gynecol. 2021 Apr 1;137(4):752-753. doi: 10.1097/AOG.0000000000004342. Obstet Gynecol. 2021. PMID: 33759825 No abstract available.

Similar articles

Cited by

References

    1. Morrow C, Naumburg EH. Dysmenorrhea. Prim Care 2009;36:19–32; vii.
    1. Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev 2014;36:104–13.
    1. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 2006;108:428–41.
    1. Schoep ME, Adang EMM, Maas JWM, De Bie B, Aarts JWM, Nieboer TE. Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women. BMJ Open 2019;9:e026186.
    1. Dawood MM. Dysmenorrhea. Glob Libr Womens Med 2008;30:154–67.

MeSH terms

Substances